8 min read

Stock Market News — July 13, 2026 — Morning Update — Last 12 Hours (Pacific Time)

Middle East tensions and Trump's Strait of Hormuz threat rattled markets Monday, while SK Hynix's record 15.4% collapse triggered a global memory chip selloff dragging down Micron, Western Digital, and Samsung. TSMC's strong AI-driven Q2 results and Intel's €5B Irish investment provided isolated bri

Executive Summary

Middle East escalation dominated Monday's session, with fresh U.S.-Iran strikes and Trump's threat to control the Strait of Hormuz rattling equity markets and sending oil prices higher. The single most important development was a record 15.4% single-day collapse in SK Hynix shares — triggering a global memory chip selloff that dragged down Micron, Western Digital, Samsung, Marvell, and Arm. Despite geopolitical headwinds, pockets of strength emerged in AI infrastructure, European oil majors, and select biotech names.


Sentiment Breakdown

Sentiment Count Percentage
🟢 Bullish 82 40%
🟡 Neutral 38 19%
🔴 Bearish 85 41%

Net Sentiment: Slightly Bearish — Geopolitical risk and the memory chip crash outweigh isolated bright spots in AI infrastructure and biotech upgrades.


Top Market-Moving Headlines

🔴 Geopolitics | Wall Street slips as tech stocks fall, Trump says reinstating Iran blockade
Market Impact: Strait of Hormuz threat rattled risk appetite across equities. S&P 500 and Nasdaq opened lower as sentiment soured on escalating U.S.-Iran hostilities.

🔴 Semiconductors | SK Hynix's record plunge drags down global chip stocks
Market Impact: SK Hynix's record 15.4% single-day drop cascaded into Micron (-5.1%), Western Digital (-5.4%), Samsung (-10.7%), Marvell (-6.6%), and Arm (-8.0%).

🟢 Semiconductors | TSMC posts record revenue in second quarter on AI demand
Market Impact: TSMC reported Q2 revenue up 36% YoY, underscoring that AI-driven chip demand remains robust even as memory faces a severe correction.

🔴 Legal | US appeals court revives private lawsuits linking Tylenol to autism
Market Impact: Kenvue shares fell 1% as over 500 revived lawsuits create meaningful litigation overhang for the Tylenol brand owner.

🔴 Tech/Legal | California, 11 states suing to block Paramount's $110 billion Warner Bros deal
Market Impact: A 12-state coalition lawsuit introduces serious regulatory risk to one of the largest media mergers in history.

🟢 IPO | Shein targets up to $3 billion Hong Kong IPO by August
Market Impact: Shein's imminent listing — with executive chairman stepping down ahead of completion — marks a major milestone for the fast-fashion giant and Hong Kong's IPO market.

🟢 Semiconductors/Capex | Intel announces $5.7 billion AI-driven capital investment in Ireland
Market Impact: Intel's €5B Irish plant expansion signals continued commitment to advanced manufacturing despite its stock sliding 4.6% on the memory selloff.

🔴 Autos | Volkswagen CEO flags 50,000 extra job cuts to staff as costs squeezed
Market Impact: VW's potential additional 50,000 layoffs highlight deepening structural pressure on legacy automakers competing with lower-cost rivals.

🟢 AI Infrastructure | Meta expands Louisiana data center to 5 gigawatts, investment crosses $50 billion
Market Impact: Meta's 5GW data center expansion — with cumulative investment exceeding $50B — reinforces the hyperscaler AI infrastructure buildout thesis.

🟢 AI/Energy | White House to rally utilities, data centers for AI power cost pledge
Market Impact: A White House-coordinated initiative to manage AI power costs signals growing policy attention to the energy demands of the AI boom.

🔴 Smartphones/Memory | Global smartphone shipments in second quarter hit lowest in 13 years on memory chip crunch
Market Impact: An 11% drop in Q2 smartphone shipments to a 13-year low directly explains the memory chip sector's brutal selloff.

🟢 Defense Tech | Helsing raises $1.8 billion at $18 billion valuation
Market Impact: German AI defense firm Helsing's massive funding round at an $18B valuation reflects surging European defense investment appetite.

🔴 Autos | TransDigm stock falls after Stellant acquisition withdrawal
Market Impact: TDG shares fell 4.5% after withdrawing from its proposed Stellant acquisition, removing an expected growth catalyst.

🟢 Retail/Autos | California offering $3,500 EV rebates to first-time buyers
Market Impact: California's new state EV rebate program could meaningfully stimulate demand for EVs, benefiting automakers and charging infrastructure.

🟢 Biotech | Agenus stock surges more than 110% on financing announcement
Market Impact: Agenus surged 110%+ after announcing an $85M private placement, a dramatic single-day move in the immuno-oncology space.

🔴 Aerospace/Space | SpaceX shares continue lower, hit lowest level since IPO
Market Impact: SpaceX stock dropped 3.35% to $140.49, its lowest since going public, as geopolitical risk and sector rotation weighed on growth names.

🟢 Streaming/Media | Ditching streaming could boost Disney stock by 40%, Wells Fargo says
Market Impact: Wells Fargo's bold note arguing Disney should exit streaming sent shockwaves through media, with Benchmark simultaneously initiating Disney at Buy.

🟢 Financials | Bank of America hires nine senior investment bankers to target US middle market
Market Impact: BofA's aggressive middle-market expansion signals confidence in deal flow recovery and intensifying competition for IB market share.

🔴 Memory/Hardware | Samsung Electronics stock plunges 10.7% on memory chip crunch
Market Impact: Samsung's near-11% single-day drop — its worst in years — underscores how severely the memory supply/demand imbalance is hitting the sector's largest players.

🟢 Pharma/Biotech | Q32 Bio stock surges 60% on positive alopecia areata trial data
Market Impact: Positive 36-week topline results in alopecia areata drove a 60% surge, highlighting continued investor appetite for clinical-stage biotech catalysts.


Tickers in Focus

Ticker Price / Change Context
KVUE -1.0% Kenvue; autism lawsuit revival, 16,298 options contracts traded
AGEN +110.3% Agenus; $85M private placement financing announced
APP -9.4% Applovin; sector-wide tech rotation, trading at $459.50
ARM -8.0% Arm Holdings ADR; chip sector selloff, at $297.39
MRVL -6.6% Marvell Technology; memory chip contagion, at $220.30
MU -5.1% Micron Technology; SK Hynix fallout, at $929.50
WDC -5.4% Western Digital; memory selloff, at $551
INTC -4.6% Intel; memory selloff despite $5.7B Ireland investment, at $104.81
TDG -4.5% TransDigm; Stellant acquisition withdrawal
005930.KS -10.7% Samsung Electronics; memory chip crunch, at ₩254,500
000660.KS -15.4% SK Hynix; record single-day plunge, at ₩1,845,000
TSLA -3.0% Tesla; bearish engulfing at $393 support
MSFT 🟡 Microsoft; coiling at range edge, breakout tension
AAPL 🟢 Apple; Citi raises PT to $365, maintains Buy
NIO +1.5% Nio; Goldman upgrades to Buy, raises PT
DECK +3.5% Deckers Outdoor; Jefferies upgrades to Buy
SHAK 🟡 Shake Shack; 6,795 options contracts, call volume surge
ASO 🟡 Academy Sports; options at 7-month high, 5,350 contracts
FLUT 🟡 Flutter Entertainment; 2,690 options contracts traded
SAIA +3.7% Saia; BofA upgrade to Buy
MGM +2.4% MGM Resorts; deal talks with Diller reported
QTTB +60% Q32 Bio; positive alopecia areata 36-week trial data
PLSM +160% Pulsenmore; selected for Israel AI program
VEEE +85% Twin Vee PowerCats; strategic merger announcement
WMB +1.0% Williams; $5.34B Blackstone joint venture
CACI +2.0% CACI International; southern border drone defense deal
FHB -4.8% First Hawaiian; TriCo Bancshares acquisition
TCBK +7.0% TriCo Bancshares; acquisition by First Hawaiian
VOD +3.8% Vodafone; Niel stake fuels turnaround hopes
AZN -1.2% AstraZeneca; HSBC downgrade to Hold
BIIB 🟢 Biogen; Truist upgrades to Buy, PT raised to $235
DIS 🟢 Disney; Benchmark initiates Buy at $115; Wells Fargo streaming exit thesis
ABBV +0.8% AbbVie; BMO bullish note
COST 🟡 Costco; RBC initiates Sector Perform, flags rich valuation
SHOP 🟢 Shopify; Jefferies upgrades to Buy, PT $160
PZZA -1.9% Papa John's; BofA downgrades to Underperform
AMEX/AXP 🟢 American Express; JPMorgan upgrades to Overweight
MA 🟡 Mastercard; exploring sale of UK Vocalink stake
META 🟢 Meta; 5GW Louisiana data center, $50B+ cumulative investment
SpaceX -3.35% SpaceX; at $140.49, lowest since IPO
ONCY +5.9% Oncolytics Biotech; FDA meeting plans for trial
BW +4.3% Babcock & Wilcox; $50M buyback program
EXFY +3.5% Expensify; new consolidated travel billing feature
KVYO +2.4% Klaviyo; new CFO appointment

Market Implications

Memory Chip Sector in Crisis Mode. The SK Hynix-led collapse — triggered by a 13-year low in global smartphone shipments — is not a one-day story. With Samsung, Micron, Western Digital, Marvell, and Arm all taking significant hits, the memory supply glut thesis is now front and center. Investors should watch whether TSMC's record AI-driven revenue can decouple the logic/foundry segment from the memory carnage, or whether the contagion broadens into the broader semiconductor equipment space.

Geopolitical Risk Premium Is Back. Trump's Strait of Hormuz threat and fresh U.S.-Iran strikes have reintroduced a meaningful geopolitical risk premium into oil and equities. European airlines are already feeling the pressure, while oil majors are benefiting. If the Hormuz situation escalates further, energy prices could spike sharply — creating a stagflationary headwind just as Q2 earnings season kicks off this week.

AI Infrastructure Spending Remains Unshaken. Despite the risk-off tone, Meta's 5GW data center expansion, Intel's $5.7B Irish investment, and the White House's utility-AI power initiative all signal that hyperscaler capex is accelerating — not decelerating. This divergence between AI infrastructure winners and memory/hardware losers is likely to define sector rotation into Q3. Earnings from AI-exposed names this week will be critical in determining whether the market rewards or punishes the spending.


Vlad's Key Takeaways

  • 🔴 SK Hynix — Record 15.4% single-day plunge triggered a global memory chip selloff; the worst is not necessarily over.
  • 🔴 Samsung — Down 10.7%; the memory chip crunch is hitting even the world's largest chipmaker hard.
  • 🔴 Smartphone Shipments — Q2 global shipments fell 11% to a 13-year low, the root cause of the memory sector collapse.
  • 🟢 TSMC — Q2 revenue up 36% YoY; AI demand is keeping the foundry business insulated from memory pain.
  • 🔴 Iran/Hormuz — Trump's Strait of Hormuz threat is the biggest macro wildcard; oil and equities are pricing in elevated risk.
  • 🟢 Meta — 5GW Louisiana data center with $50B+ cumulative investment signals hyperscaler AI capex is accelerating.
  • 🔴 Applovin — Down 9.4%; tech rotation is hitting high-multiple growth names hardest.
  • 🟢 Agenus — Up 110%+ on $85M private placement; biotech remains a bright spot amid broader weakness.
  • 🔴 Paramount/Warner Bros. — 12-state lawsuit to block $110B deal introduces serious regulatory risk to the merger.
  • 🟢 Shein — Targeting $2-3B Hong Kong IPO by August; executive chairman stepping down ahead of listing.
  • 🟢 Intel — $5.7B Ireland investment despite stock sliding 4.6%; long-term manufacturing commitment intact.
  • 🔴 VW — Potential 50,000 additional job cuts highlight the existential cost pressure on legacy automakers.
  • 🟢 Shopify — Jefferies upgrades to Buy with $160 PT on AI commerce tailwinds; 30% upside seen.
  • 🟢 Deckers/HOKA — Jefferies upgrades to Buy; HOKA growth slowdown viewed as oversold opportunity.
  • 🔴 SpaceX — Shares at lowest since IPO at $140.49; geopolitical and sector headwinds weighing.
  • 🟢 Helsing — $1.8B raise at $18B valuation; European defense AI investment is accelerating rapidly.
  • 🟢 Saia — Up 3.7% on BofA upgrade; LTL freight sector showing resilience amid broader weakness.
  • 🔴 AstraZeneca — HSBC downgrades to Hold with slashed PT; "tough path ahead" signals near-term caution.
  • 🟢 Nio — Goldman upgrades to Buy; compelling valuation and strong growth make it a standout in Chinese EV space.
  • 🟢 Q32 Bio — Up 60% on positive alopecia areata trial data; clinical-stage biotech catalysts still driving outsized moves.

Thematic Analysis

Memory Chip Meltdown & Semiconductor Bifurcation 🔴
SK Hynix's record collapse — driven by a 13-year low in smartphone shipments — exposed a deep fault line in the semiconductor sector. Memory names (Samsung, Micron, Western Digital, SanDisk) are in freefall, while AI logic plays (TSMC +36% revenue) are holding up. This bifurcation is likely to persist: memory oversupply is a structural problem, while AI chip demand remains a secular tailwind. Investors should treat these as two distinct sectors, not one.

Middle East Escalation & Oil Shock Risk 🔴
Fresh U.S.-Iran strikes and Trump's Strait of Hormuz threat have reignited geopolitical risk premiums across global markets. European airlines fell, oil stocks rallied, and equity indices opened lower. If Hormuz disruption materializes, the inflationary shock could complicate the Fed's path and compress corporate margins — particularly for energy-intensive industries. JPMorgan, notably, is calling Iran-driven selloffs buying opportunities.

AI Infrastructure Supercycle Continues 🟢
Meta's 5GW data center, Intel's $5.7B Irish plant, the White House's AI power initiative, and Mitsubishi Estate's ¥1.5T data center plan all point to an AI infrastructure buildout that is accelerating globally. Utilities, power infrastructure, and AI-adjacent hardware suppliers remain well-positioned. The key risk is whether power costs and regulatory scrutiny begin to constrain the pace of investment.

Geopolitical M&A & Regulatory Headwinds 🔴
The 12-state lawsuit against the Paramount-Warner Bros. deal, Mastercard exploring a Vocalink stake sale under regulatory pressure, and Shein's complex IPO governance (executive chairman stepping down) all highlight how geopolitical and regulatory forces are reshaping corporate strategy. Deal risk is elevated, and antitrust scrutiny appears to be intensifying across media, fintech, and tech.

Biotech & Healthcare: Selective Bright Spots 🟢
Amid broad market weakness, biotech delivered some of the session's most dramatic moves: Agenus +110%, Q32 Bio +60%, Pulsenmore +160%. Analyst upgrades for Biogen (Truist, Buy) and AbbVie (BMO bullish) add to the constructive tone. Clinical catalysts and pipeline optionality are driving outsized returns in a risk-off environment — suggesting biotech is acting as a relative safe haven for growth-oriented capital.


Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

👉 This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/